Skip to content
ONTARIO SECURITIES COMMISSION APPROVES AVICANNA’S APPLICATION FOR MANAGEMENT CEASE TRADE ORDER
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Rho Phyto
Education
Avicenna Academy
Symposium
MyMedi.ca
Contact
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Rho Phyto
Education
Avicenna Academy
Symposium
MyMedi.ca
Contact
Instagram
Twitter
Linkedin
Linkedin
Twitter
Instagram
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Rho Phyto
Education
Avicenna Academy
Symposium
MyMedi.ca
Contact
×
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Rho Phyto
Education
Avicenna Academy
Symposium
MyMedi.ca
Contact
News & Press
Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update
28 April 2026
Annual General and Special Meeting of Shareholders to be held May 7, 2026
21 April 2026
Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics
20 April 2026
Avicanna Announces Changes to its Board of Directors
6 April 2026
Avicanna Reports Full Year 2025 Audited Financial Statements
1 April 2026
Avicanna Subsidiary SMGH Completes First Commercial Export to Australia
26 March 2026
« Prev
1
2
3
4
5
6
7
Next »